These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 16687108)
1. [LRRK2 is a major gene in North African parkinsonism]. Lesage S; Dürr A; Brice A Med Sci (Paris); 2006 May; 22(5):470-1. PubMed ID: 16687108 [No Abstract] [Full Text] [Related]
2. Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain. González-Fernández MC; Lezcano E; Ross OA; Gómez-Esteban JC; Gómez-Busto F; Velasco F; Alvarez-Alvarez M; Rodríguez-Martínez MB; Ciordia R; Zarranz JJ; Farrer MJ; Mata IF; de Pancorbo MM Parkinsonism Relat Disord; 2007 Dec; 13(8):509-15. PubMed ID: 17540608 [TBL] [Abstract][Full Text] [Related]
3. Unilateral pallidotomy in a patient with parkinsonism and G2019S LRRK2 mutation. Munhoz RP; Teive HA; Francisco AN; Raskin S; Rogaeva E Mov Disord; 2009 Apr; 24(5):791-2; author reply 792. PubMed ID: 19012346 [No Abstract] [Full Text] [Related]
4. Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism. Ruffmann C; Giaccone G; Canesi M; Bramerio M; Goldwurm S; Gambacorta M; Rossi G; Tagliavini F; Pezzoli G Neuropathol Appl Neurobiol; 2012 Jun; 38(4):382-6. PubMed ID: 21883375 [No Abstract] [Full Text] [Related]
6. The role of the LRRK2 gene in Parkinsonism. Li JQ; Tan L; Yu JT Mol Neurodegener; 2014 Nov; 9():47. PubMed ID: 25391693 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa. Jasinska-Myga B; Kachergus J; Vilariño-Güell C; Wider C; Soto-Ortolaza AI; Kefi M; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Yahmed SB; Sassi SB; Zouari M; El Euch G; Ross OA; Hentati F; Farrer MJ Mov Disord; 2010 Oct; 25(13):2052-8. PubMed ID: 20721913 [TBL] [Abstract][Full Text] [Related]
8. G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Ozelius LJ; Foroud T; May S; Senthil G; Sandroni P; Low PA; Reich S; Colcher A; Stern MB; Ondo WG; Jankovic J; Huang N; Tanner CM; Novak P; Gilman S; Marshall FJ; Wooten GF; Chelimsky TC; Shults CW; Mov Disord; 2007 Mar; 22(4):546-9. PubMed ID: 17230458 [TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Schüpbach M; Lohmann E; Anheim M; Lesage S; Czernecki V; Yaici S; Worbe Y; Charles P; Welter ML; Pollak P; Dürr A; Agid Y; Brice A Mov Disord; 2007 Jan; 22(1):119-22. PubMed ID: 17080443 [TBL] [Abstract][Full Text] [Related]
10. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Rajput A; Dickson DW; Robinson CA; Ross OA; Dächsel JC; Lincoln SJ; Cobb SA; Rajput ML; Farrer MJ Neurology; 2006 Oct; 67(8):1506-8. PubMed ID: 17060589 [TBL] [Abstract][Full Text] [Related]
12. Olfactory heterogeneity in LRRK2 related Parkinsonism. Silveira-Moriyama L; Munhoz RP; de J Carvalho M; Raskin S; Rogaeva E; de C Aguiar P; Bressan RA; Felicio AC; Barsottini OG; Andrade LA; Chien HF; Bonifati V; Barbosa ER; Teive HA; Lees AJ Mov Disord; 2010 Dec; 25(16):2879-83. PubMed ID: 20818658 [TBL] [Abstract][Full Text] [Related]
13. Co-occurrence of sporadic parkinsonism and late-onset Alzheimer's disease in a Brazilian male with the LRRK2 p.G2019S mutation. Santos-Rebouças CB; Abdalla CB; Baldi FJ; Martins PA; Corrêa JC; Gonçalves AP; Cunha MS; Borges MB; Pereira JS; Laks J; Pimentel MM Genet Test; 2008 Dec; 12(4):471-3. PubMed ID: 19072560 [TBL] [Abstract][Full Text] [Related]
14. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Klein C; Lohmann-Hedrich K; Rogaeva E; Schlossmacher MG; Lang AE Lancet Neurol; 2007 Jul; 6(7):652-62. PubMed ID: 17582365 [TBL] [Abstract][Full Text] [Related]
15. LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance. Hentati F; Trinh J; Thompson C; Nosova E; Farrer MJ; Aasly JO Neurology; 2014 Aug; 83(6):568-9. PubMed ID: 25008396 [TBL] [Abstract][Full Text] [Related]
16. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. Lesage S; Dürr A; Tazir M; Lohmann E; Leutenegger AL; Janin S; Pollak P; Brice A; N Engl J Med; 2006 Jan; 354(4):422-3. PubMed ID: 16436781 [No Abstract] [Full Text] [Related]
17. Low disease risk in relatives of north african lrrk2 Parkinson disease patients. Troiano AR; Elbaz A; Lohmann E; Belarbi S; Vidailhet M; Bonnet AM; Lesage S; Pollak P; Cazeneuve C; Borg M; Feingold J; Dürr A; Tazir M; Brice A; Neurology; 2010 Sep; 75(12):1118-9. PubMed ID: 20855856 [No Abstract] [Full Text] [Related]
18. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Zimprich A; Biskup S; Leitner P; Lichtner P; Farrer M; Lincoln S; Kachergus J; Hulihan M; Uitti RJ; Calne DB; Stoessl AJ; Pfeiffer RF; Patenge N; Carbajal IC; Vieregge P; Asmus F; Müller-Myhsok B; Dickson DW; Meitinger T; Strom TM; Wszolek ZK; Gasser T Neuron; 2004 Nov; 44(4):601-7. PubMed ID: 15541309 [TBL] [Abstract][Full Text] [Related]
19. New mutations causing familial parkinsonism. Rana AQ; Al-Harbi T; Khan O; Patel A Ann Acad Med Singap; 2013 Jun; 42(6):307-8. PubMed ID: 23842774 [No Abstract] [Full Text] [Related]
20. LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation. Marras C; Klein C; Lang AE; Wakutani Y; Moreno D; Sato C; Yip E; Munhoz RP; Lohmann K; Djarmati A; Bi A; Rogaeva E Neurobiol Aging; 2010 Apr; 31(4):721-2. PubMed ID: 18644660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]